[go: up one dir, main page]

AT364470B - Verfahren zur herstellung von thymosin alfa1 oder seinem (asn2)-analogen - Google Patents

Verfahren zur herstellung von thymosin alfa1 oder seinem (asn2)-analogen

Info

Publication number
AT364470B
AT364470B AT0286178A AT286178A AT364470B AT 364470 B AT364470 B AT 364470B AT 0286178 A AT0286178 A AT 0286178A AT 286178 A AT286178 A AT 286178A AT 364470 B AT364470 B AT 364470B
Authority
AT
Austria
Prior art keywords
alfa1
thymosine
asn2
analog
producing
Prior art date
Application number
AT0286178A
Other languages
English (en)
Other versions
ATA286178A (de
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/871,563 external-priority patent/US4116951A/en
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ATA286178A publication Critical patent/ATA286178A/de
Application granted granted Critical
Publication of AT364470B publication Critical patent/AT364470B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06086Dipeptides with the first amino acid being basic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/57581Thymosin; Related peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043Leu-amino acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT0286178A 1977-04-22 1978-04-21 Verfahren zur herstellung von thymosin alfa1 oder seinem (asn2)-analogen AT364470B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78989877A 1977-04-22 1977-04-22
US05/871,563 US4116951A (en) 1977-04-22 1978-01-23 [Asn2 ]-thymosin α1 and analogs thereof

Publications (2)

Publication Number Publication Date
ATA286178A ATA286178A (de) 1981-03-15
AT364470B true AT364470B (de) 1981-10-27

Family

ID=27120967

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0286178A AT364470B (de) 1977-04-22 1978-04-21 Verfahren zur herstellung von thymosin alfa1 oder seinem (asn2)-analogen

Country Status (18)

Country Link
JP (1) JPS53137914A (de)
AT (1) AT364470B (de)
CA (1) CA1113088A (de)
CH (3) CH641152A5 (de)
DE (1) DE2817082A1 (de)
DK (1) DK147918C (de)
ES (1) ES469016A1 (de)
FI (1) FI781241A (de)
FR (2) FR2401134A1 (de)
GB (1) GB1590668A (de)
GR (1) GR71886B (de)
HU (1) HU180783B (de)
IT (1) IT1113134B (de)
LU (1) LU79488A1 (de)
NL (1) NL7804364A (de)
NO (2) NO781404L (de)
PT (1) PT67937B (de)
SE (1) SE447262B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4116951A (en) * 1977-04-22 1978-09-26 Hoffmann-La Roche Inc. [Asn2 ]-thymosin α1 and analogs thereof
DE2919592A1 (de) * 1979-05-15 1981-01-15 Max Planck Gesellschaft Verfahren zur herstellung von thymosin- alpha 1 und derivaten davon
EP0033384B1 (de) * 1980-01-18 1984-02-15 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Thymosin-alpha-1-Fragmente enthaltende Arzneimittel mit immunstimulierender Wirkung, und Thymosin-alpha-1-Fragmente
US4339427A (en) * 1980-04-14 1982-07-13 Hoffmann-La Roche Inc. Radioimmunoassay of thymosinα
EP0056594B1 (de) * 1981-01-14 1984-09-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Thymosin-alpha-1-Fragmente enthaltende Arzneimittel mit immunregulierender Wirkung und Thymosin-alpha-1-Fragmente
CN1058500C (zh) * 1993-02-03 2000-11-15 施塞克龙药品公司 胸腺素α-1衍生物
US6262230B1 (en) * 1994-01-28 2001-07-17 Sciclone Pharmaceuticals Inc. Analogs of thymosin α1

Also Published As

Publication number Publication date
NO781404L (no) 1978-10-24
FR2401134B1 (de) 1983-09-30
NL7804364A (nl) 1978-10-24
CA1113088A (en) 1981-11-24
JPS53137914A (en) 1978-12-01
IT7822629A0 (it) 1978-04-21
LU79488A1 (de) 1979-05-25
PT67937B (en) 1980-04-07
NO821608L (no) 1978-10-24
DE2817082A1 (de) 1978-11-02
ATA286178A (de) 1981-03-15
IT1113134B (it) 1986-01-20
GR71886B (de) 1983-08-04
DK147918C (da) 1985-08-19
PT67937A (en) 1978-05-01
FI781241A (fi) 1978-10-23
CH641153A5 (en) 1984-02-15
SE447262B (sv) 1986-11-03
GB1590668A (en) 1981-06-03
CH640218A5 (en) 1983-12-30
FR2405926B1 (de) 1983-09-09
NO148924C (no) 1984-01-11
DK169478A (da) 1978-10-23
DK147918B (da) 1985-01-07
NO148924B (no) 1983-10-03
SE7804612L (sv) 1978-12-20
CH641152A5 (en) 1984-02-15
HU180783B (en) 1983-04-29
FR2405926A1 (fr) 1979-05-11
FR2401134A1 (fr) 1979-03-23
ES469016A1 (es) 1980-01-01

Similar Documents

Publication Publication Date Title
AT367438B (de) Verfahren zur herstellung von oligoimiden
AT356096B (de) Verfahren zur herstellung von furokumarinen
AT358548B (de) Verfahren zur herstellung von 2-aethylhexanol
AT358559B (de) Verfahren zur herstellung von o-methallyloxy- phenol
AT359283B (de) Verfahren zur herstellung von befestigern
AT360504B (de) Verfahren zur herstellung von m-chloranilinen
AT366032B (de) Verfahren zur herstellung von moranolin und n-methylmoranolin
AT356643B (de) Verfahren zur herstellung von acylcyaniden
AT364470B (de) Verfahren zur herstellung von thymosin alfa1 oder seinem (asn2)-analogen
AT360652B (de) Verfahren zur herstellung von 3-jod- und 3- -bromrifamycin s
AT360154B (de) Verfahren zur herstellung von aminoglycosid- -antibiotka
AT377741B (de) Verfahren zur herstellung von chlordioxid
DD133661A1 (de) Verfahren zur herstellung von aethern und/oder aetheralkoholen
AT360648B (de) Verfahren zur herstellung von p-hydroxy-alpha- -aminobenzylpenicillin
AT356642B (de) Verfahren zur herstellung von acylcyaniden
AT347440B (de) Verfahren zur herstellung von benzoylcyanid
AT366036B (de) Verfahren zur herstellung von 3-pyridazonen
AT359483B (de) Verfahren zur herstellung von benzoylcyanid
AT352104B (de) Verfahren zur herstellung von n-cyanoalkyl-p- halogenphenoxy-isobutyramiden
AT365590B (de) Verfahren zur herstellung von apovincamin
AT368523B (de) Verfahren zur herstellung von bufadienolid- und bufatrienolidaethern
AT359510B (de) Verfahren zur herstellung von benzylpyrimidinen
AT361497B (de) Verfahren zur herstellung von alkylthiosemi- carbaziden
AT358021B (de) Verfahren zur herstellung von benzoylcyanid
AT360151B (de) Verfahren zur herstellung von penicillinen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee